美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

減肥藥

1,143.99

+9.310.82%

漲家數：5

跌家數：2

平家數：- -

市盈率：- -

高：1,154.62

開：1,132.71

低：1,132.71

收：1,134.68

成交量：1.34億

成交額：85.86億

市值：1.22萬億

流通市值：1.15萬億

資料載入中...

大摩下調禮來目標價至1028美元

諾和諾德8月12日成交額為5.56億美元

亨利醫藥回應新加坡國際商事法庭裁決：將向仲裁庭證明諾和諾德終止開發公司藥物是錯誤的

8月13日亨利醫藥（KBP）在官網發佈聲明回應新加坡國際商事法庭（SICC）作出的進一步裁定。該裁定決定維持對KBP及其

禮來8月12日成交額為44.22億美元

這家行業巨頭，一天損失1000億美金

中国新闻周刊

2025國談初審大擴容：傳奇CAR-T缺席；阿爾茨海默新藥入圍；輝瑞、吉利德、BMS再戰“落榜”品種（附商保目錄）

CHC医疗传媒

Altimmune, Inc.8月12日成交額為1988.51萬美元

禮來公司的減肥藥在一項關鍵試驗中表現令人失望後該公司首席執行官David Ricks和其他內部人士在隨後的股票拋售中總共

輝瑞週二聲明表示FDA告知可能不會延續其對6個月至4歲兒童的長期緊急使用授權。輝瑞稱已申請在即將到來的秋冬季維持該授權並

輝瑞公司週二向媒體證實美國食品藥品監督管理局(FDA)正考慮撤銷其新冠疫苗對5歲以下健康兒童的緊急使用授權。

德州總檢察長起訴禮來公司涉嫌賄賂醫療服務提供者

WLFI國庫戰略ALT5 Sigma股價現報5.45美元，較高點跌超40%

輝瑞藥物聯合療法後期試驗取得積極成果

美國食品藥品監督管理局(FDA)正在考慮撤銷輝瑞向5歲以下兒童提供COVID疫苗的授權。

據彭博新聞社報道，美國食品和藥物管理局考慮撤銷輝瑞公司為 5 歲以下兒童提供的 COVID 疫苗

諾和諾德（Novo Nordisk）執行副總裁盧多維克・埃爾福戈特（Ludovic Helfgott）出售股票套現 39

高盛最新研報以“2Q25 EPS更新”為主題其中重點對Amylyx(AMLX.US)、CG Oncology(CGON.

World Liberty Financial代幣WLFI在ALT5交易中估值0.2美元

輝瑞的聯合療法提高了膀胱癌試驗的生存率

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4599/news?page=5"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"減肥藥","latestPrice":1143.9899,"timestamp":1755633599999,"preClose":1134.6772,"halted":0,"volume":133544118,"delay":0,"changeRate":0.008207,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":9.312622,"latestTime":"08-19 16:00:00 EDT","open":1132.7133,"high":1154.6233,"low":1132.71,"amount":8585985464.233141,"amplitude":0.019312,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1755648000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":8.282627,"peRate":24.521837,"turnoverRate":0.012616,"increases":5,"decrements":2,"flats":0,"marketCap":1215941649984,"floatMarketCap":1145475764960},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1154.6233,"amplitude":0.019312,"preClose":1134.6772,"low":1132.71,"pbRate":"8.282627","latestPrice":1143.9899,"volume":133544118,"delay":0,"open":1132.7133,"prevYearClose":1305.0607,"prevWeekClose":1132.9453,"prevMonthClose":1136.9344,"prevQuarterClose":1245.5326,"fiveDayClose":1057.4221,"twentyDayClose":1253.981,"sixtyDayClose":1173.4421,"secType":"PLATE","market":"US","turnoverRate":0.012616,"peRate":24.521837,"marketCap":1215941649984,"floatMarketCap":1145475764960,"timestamp":1755633599999,"nameCN":"減肥藥"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":5,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2559860396","title":"大摩下調禮來目標價至1028美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559860396","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559860396?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 17:27","pubTimestamp":1755077271,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2361044865.SGD","LU0640476718.USD","LU1035775433.USD","LU1366192091.USD","LU1061106388.HKD","SGXZ99366536.SGD","LU1064131342.USD","LU0943347566.SGD","LU2264538146.SGD","LU0786609619.USD","LU0889565916.HKD","LU1720051108.HKD","LU0006306889.USD","LU2063271972.USD","LU2265009873.SGD","LU2361045086.USD","LU2471134523.USD","BK4581","LU0097036916.USD","LLY","LU0708995401.HKD","LU2237443549.SGD","LU2237443895.HKD","LU2324357040.USD","LU1988902786.USD","IE0004445239.USD","SGXZ51526630.SGD","LU0061475181.USD","SG9999018865.SGD","IE00B2B36J28.USD","LU1720051017.SGD","LU2746668461.USD","LU0432979614.USD","LU2357305700.SGD","LU2602419157.SGD","SG9999014898.SGD","BK4599","LU2491050071.SGD","LU0689472784.USD","LU2468319806.SGD","IE00B1BXHZ80.USD","LU0266013472.USD","SG9999015986.USD","LU2750360641.GBP","IE00BJT1NW94.SGD","BK4588","LU0122379950.USD","LU0234572021.USD","LU2552382132.HKD","LU2237443465.HKD"],"gpt_icon":0},{"id":"2559671867","title":"諾和諾德8月12日成交額為5.56億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559671867","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559671867?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 13:06","pubTimestamp":1755061562,"startTime":"0","endTime":"0","summary":"美东时间2025年8月12日，诺和诺德成交额为5.56亿美元，成交额较昨日减少31.58%，当日成交量为1113.19万股。诺和诺德于2025年8月12日跌0.18%，报49.78美元，该股过去5个交易日涨5.42%，年初至今跌41.35%，过去60日跌24.75%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813130613a6e31b11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813130613a6e31b11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4588","IE00BKVL7J92.USD","BK4599","LU1093756168.USD","BK4585","NVO","BK4007","LU0154236417.USD","BK4532"],"gpt_icon":1},{"id":"2559767716","title":"亨利醫藥回應新加坡國際商事法庭裁決：將向仲裁庭證明諾和諾德終止開發公司藥物是錯誤的","url":"https://stock-news.laohu8.com/highlight/detail?id=2559767716","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559767716?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 12:00","pubTimestamp":1755057615,"startTime":"0","endTime":"0","summary":"格隆汇8月13日｜亨利医药今日在官网发布声明，回应新加坡国际商事法庭作出的进一步裁定。该声明称，KBP已先于诺和诺德启动仲裁程序。在SICC作出判决后，诺和诺德所申请禁令的有效性将会在仲裁程序中予以判定。前述判决中，SICC审查了争议核心的一系列问题，包括临床试验的开展及尽职调查的充分性。黄振华在此次声明中表示，KBP认为，诺和诺德终止开发Ocedurenone是错误的，因为该药有望惠及患者。KBP将向仲裁庭证明这一点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813120515974494ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813120515974494ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BKVL7J92.USD","BK4007","BK4532","BK4599","IE00BZ1G4Q59.USD","LU1093756325.SGD","NVO","LU1093756168.USD","BK4588","LU0154236417.USD","BK4585"],"gpt_icon":0},{"id":"2559676104","title":"8月13日亨利醫藥（KBP）在官網發佈聲明回應新加坡國際商事法庭（SICC）作出的進一步裁定。該裁定決定維持對KBP及其","url":"https://stock-news.laohu8.com/highlight/detail?id=2559676104","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559676104?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 11:58","pubTimestamp":1755057504,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BKVL7J92.USD","BK4599","LU0188438112.USD","SG9999003826.SGD","S68.SI","BK6516","FSTM.SI","ES3.SI","LU0831103253.SGD","BK4007","SG9999004360.SGD","NVO","LU2242646821.SGD","SG9999000343.SGD","159938","BK4588","LU1119993845.HKD","LU0205439572.USD","LU0154236417.USD","LU2401740654.USD","LU0877626530.USD","SG9999001135.SGD","SG9999013478.USD","LU2242646235.USD","SG9999001846.SGD","LU0326948709.USD","LU2242652126.USD","BK4585","SG9999013486.USD","LU1920062954.HKD","STI.SI","LU1093756168.USD","BK4532","SG9999006266.SGD","LU1093756325.SGD","LU0898667661.SGD","SGXZ58947870.SGD","09939","BK1574","BK6523","LU1920063259.USD","BK1161","SGXZ27511609.SGD","SG9999013460.SGD","LU0192582467.USD","BK1515","IE00BZ1G4Q59.USD","BK6033","SG9999016042.SGD","FSTAS.SI"],"gpt_icon":0},{"id":"2559676049","title":"禮來8月12日成交額為44.22億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559676049","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559676049?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 11:51","pubTimestamp":1755057106,"startTime":"0","endTime":"0","summary":"美东时间2025年8月12日，礼来成交额为44.22亿美元，成交额较昨日减少38.99%，当日成交量为692.50万股。礼来于2025年8月12日涨0.66%，报639.43美元，该股过去5个交易日跌16.52%，年初至今跌16.86%，过去60日跌12.63%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-12|44.22亿|-38.99%|692.50万|#|2025-08-11|72.49亿|-19.06%|1129.42万|#|2025-08-08|89.56亿|-46.67%|1412.51万|#|2025-08-07|167.93亿|372.40%|2610.16万|#|2025-08-06|35.55亿|28.47%|475.21万|礼来制药公司是一家专注于神经科学、心脏代谢、癌症和免疫学的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813115156a4856987&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813115156a4856987&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GB00BDT5M118.USD","LU2237443978.SGD","LU1057294990.SGD","LU1064131342.USD","SG9999018857.SGD","LU0289739699.SGD","LU0882574055.USD","LU2471134796.USD","LU2491049909.HKD","LU0640476718.USD","BK4588","LU0256863902.USD","LU0943347566.SGD","LU0316494557.USD","LU1551013342.USD","LLY","LU2462157665.USD","LU0689472784.USD","LU0234572021.USD","SG9999015978.USD","LU2746668974.SGD","LU1868836757.USD","SG9999013999.USD","LU1989771016.USD","BK4581","LU0432979614.USD","LU2468319806.SGD","LU0889565916.HKD","LU0238689110.USD","BK4599","LU0097036916.USD","LU0672654240.SGD","LU0109391861.USD","LU1280957306.USD","LU2602419157.SGD","IE00BFTCPJ56.SGD","LU0820561818.USD","LU2324357040.USD","LU2089984988.USD","LU1267930730.SGD","LU2471134523.USD","LU2112291526.USD","LU0122379950.USD","LU0823434740.USD","LU1548497426.USD","SGXZ81514606.USD","LU1551013425.SGD","LU1983299246.USD","LU0456855351.SGD","SGXZ57979304.SGD"],"gpt_icon":1},{"id":"2559608675","title":"這家行業巨頭，一天損失1000億美金","url":"https://stock-news.laohu8.com/highlight/detail?id=2559608675","media":"中国新闻周刊","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559608675?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 10:16","pubTimestamp":1755051363,"startTime":"0","endTime":"0","summary":"上周四美股开盘后，礼来的股价一度暴跌超15%，创自2000年以来最大单日跌幅，市值蒸发掉了千亿美元。次日跌势继续，股价一度跌至6000亿美元以下。替尔泊肽组平均减重22.8kg，司美格鲁肽组平均减重15.0kg。受此消息影响，诺和诺德当天市值蒸发了超600亿美元。中国市场市场研究机构Report Linker发布的《全球体重管理行业报告》提出，2021年至2027年间，中国体重管理市场预计年均增长10.6%，2027年将达到926亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813102616a4853cd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813102616a4853cd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0154236417.USD","BK4585","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1093756168.USD","BK4532","BK4007","BK4599","LU1093756325.SGD","BK4588"],"gpt_icon":1},{"id":"2559766666","title":"2025國談初審大擴容：傳奇CAR-T缺席；阿爾茨海默新藥入圍；輝瑞、吉利德、BMS再戰“落榜”品種（附商保目錄）","url":"https://stock-news.laohu8.com/highlight/detail?id=2559766666","media":"CHC医疗传媒","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559766666?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 10:00","pubTimestamp":1755050427,"startTime":"0","endTime":"0","summary":"国家医保局表示，将根据公示期间收到的反馈意见，对相关药品信息进行复核，并最终确定通过形式审查的药品名单。申报截止日前，国内共有6款CAR-T疗法获批上市。作为2021年即获批的CAR-T产品，两家企业均曾多次通过形式审查但未进复审名单。前者是国内首个批准上市的CAR-T产品，用于治疗既往接受二线或以上系统性治疗后复发或难治性大B细胞淋巴瘤成人患者。而未能入选的辉瑞、吉利德等企业今年选择再战医保。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813103346a485413f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813103346a485413f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0122379950.USD","IE0002270589.USD","BMS","BK4533","LU1066053197.SGD","IE00BLSP4239.USD","LU0456855351.SGD","SG9999002232.USD","SG9999011175.SGD","BK4550","LU1883839398.USD","LU0170899867.USD","SG9999001176.SGD","LU0058720904.USD","BK4534","LU0225771236.USD","LU0321505868.SGD","LU0985481810.HKD","BK4592","LU0234572021.USD","BK4599","SGXZ57979304.SGD","IE00B19Z3581.USD","SG9999003800.SGD","LU1023059063.AUD","LU0225284248.USD","IE00BLSP4452.SGD","LU0868494617.USD","LU0306806265.USD","CAR","SG9999001176.USD","BK4230","BK4568","BK4585","BK4581","LU1057294990.SGD","BK4588","BK4022","LU0306807586.USD","LU0321505439.SGD","IE000M9KFDE8.USD","LU0289739699.SGD","LU1066051498.USD","LU1894683348.USD","IE00B19Z3B42.SGD","SG9999002224.SGD","BK4007","SG9999013999.USD","LU1894683264.USD"],"gpt_icon":1},{"id":"2559671672","title":"Altimmune, Inc.8月12日成交額為1988.51萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559671672","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559671672?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 09:16","pubTimestamp":1755047801,"startTime":"0","endTime":"0","summary":"美东时间2025年8月12日，Altimmune, Inc.成交额为1988.51万美元，成交额较昨日增加109.56%，当日成交量为540.10万股。Altimmune, Inc.于2025年8月12日涨7.1%，报3.62美元，该股过去5个交易日跌1.36%，年初至今跌49.79%，过去60日跌37.37%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-12|1988.51万|109.56%|540.10万|#|2025-08-11|948.90万|18.24%|278.66万|#|2025-08-08|802.54万|-6.68%|230.81万|#|2025-08-07|860.04万|34.15%|243.00万|#|2025-08-06|641.12万|-31.15%|178.62万|Altimmune Inc 是一家处于临床阶段的生物制药公司，专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813091646a48515bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813091646a48515bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","ALT","LU1878469433.USD","BK4139"],"gpt_icon":0},{"id":"2559627733","title":"禮來公司的減肥藥在一項關鍵試驗中表現令人失望後該公司首席執行官David Ricks和其他內部人士在隨後的股票拋售中總共","url":"https://stock-news.laohu8.com/highlight/detail?id=2559627733","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559627733?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 07:26","pubTimestamp":1755041163,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1035775433.USD","BK4599","LU0097036916.USD","BK4533","LU2112291526.USD","IE00BJT1NW94.SGD","LU1366192091.USD","LU1127390331.HKD","BK4581","IE0009355771.USD","LU2063271972.USD","LU1974910355.USD","LU0096364046.USD","LU1868836591.USD","LU2211815571.USD","LU0471298777.SGD","SGXZ99366536.SGD","SGXZ51526630.SGD","IE0002141913.USD","BK4585","IE00B1BXHZ80.USD","LLY","LU2471134952.CNY","SG9999015978.USD","SG9999015952.SGD","LU1548497426.USD","LU0058720904.USD","IE00BK4W5M84.HKD","LU2471134796.USD","LU2552382058.USD","LU2602419157.SGD","LU0203202063.USD","SG9999017495.SGD","LU0323591593.USD","LU0943347566.SGD","LU1093756325.SGD","IE0004445239.USD","LU2237443978.SGD","SG9999018857.SGD","LU0882574055.USD","SGXZ57979304.SGD","LU2265009873.SGD","LU2417539215.USD","SG9999013999.USD","LU1868836914.USD","LU0238689110.USD","LU2750360641.GBP","LU1267930730.SGD","LU2491049909.HKD","LU1280957306.USD"],"gpt_icon":0},{"id":"2559562676","title":"輝瑞週二聲明表示FDA告知可能不會延續其對6個月至4歲兒童的長期緊急使用授權。輝瑞稱已申請在即將到來的秋冬季維持該授權並","url":"https://stock-news.laohu8.com/highlight/detail?id=2559562676","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559562676?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 03:15","pubTimestamp":1755026148,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1894683348.USD","IE00BBT3K403.USD","LU1066051498.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","BK4592","SG9999011175.SGD","LU0456855351.SGD","PFE","LU0985481810.HKD","SG9999003800.SGD","BK4585","IE00BLSP4452.SGD","LU0225284248.USD","BK4550","LU0225771236.USD","BK4588","LU0234572021.USD","SG9999001176.SGD","SG9999002232.USD","BK4568","IE00B19Z3581.USD","LU1066053197.SGD","LU0321505868.SGD","LU0170899867.USD","LU0122379950.USD","BK4599","SG9999001176.USD","LU0321505439.SGD","SGXZ57979304.SGD","IE000M9KFDE8.USD","IE00BLSP4239.USD","LU0868494617.USD","LU0058720904.USD","LU1023059063.AUD","LU1883839398.USD","SG9999013999.USD","BK4007","LU0306806265.USD","BK4581","LU0306807586.USD","IE0002270589.USD","BK4533","LU1894683264.USD","SG9999002224.SGD","LU1057294990.SGD","BK4534"],"gpt_icon":0},{"id":"2559626734","title":"輝瑞公司週二向媒體證實美國食品藥品監督管理局(FDA)正考慮撤銷其新冠疫苗對5歲以下健康兒童的緊急使用授權。","url":"https://stock-news.laohu8.com/highlight/detail?id=2559626734","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559626734?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 03:14","pubTimestamp":1755026096,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4534","LU1894683348.USD","SG9999002224.SGD","SG9999002232.USD","LU1894683264.USD","LU0868494617.USD","BK4599","BK4568","SG9999013999.USD","IE000M9KFDE8.USD","SGXZ57979304.SGD","LU0225771236.USD","159646","LU1883839398.USD","IE00BBT3K403.USD","LU1057294990.SGD","BK4533","BK4585","SG9999003800.SGD","LU0234572021.USD","LU0170899867.USD","LU0456855351.SGD","BK4592","LU1023059063.AUD","IE00B19Z3581.USD","BK4550","LU0985481810.HKD","LU1066053197.SGD","IE0002270589.USD","LU0289739699.SGD","LU0321505868.SGD","BK4588","SG9999001176.USD","PFE","SG9999001176.SGD","IE00BLSP4452.SGD","BK4581","LU0225284248.USD","SG9999011175.SGD","LU0122379950.USD","LU0058720904.USD","BK4007","LU0321505439.SGD","LU0306807586.USD","IE00B19Z3B42.SGD","LU0306806265.USD","LU1066051498.USD","IE00BLSP4239.USD"],"gpt_icon":0},{"id":"2559629170","title":"德州總檢察長起訴禮來公司涉嫌賄賂醫療服務提供者","url":"https://stock-news.laohu8.com/highlight/detail?id=2559629170","media":"英为财情","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559629170?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 01:23","pubTimestamp":1755019380,"startTime":"0","endTime":"0","summary":"Investing.com -- 德州总检察长肯·帕克斯顿(Ken Paxton)周二对礼来公司提起诉讼，指控这家美国制药商\"贿赂\"医疗服务提供者开具其药物处方。\n德州总检察长办公室表示，礼来公司涉嫌贿赂并非法诱导医疗服务提供者开具其最赚钱的药物处方。诉讼特别提到了该公司的GLP-1类药物Mounjaro和Zepbound，这些药物用于糖尿病治疗和减肥。\n\n本文由人工智能协助翻译。更多信息，请参见我们的使用条款。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cn.investing.com/news/stock-market-news/article-93CH-2933935","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"德州总检察长起诉礼来公司涉嫌贿赂医疗服务提供者","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"investing_news","symbols":["LU0672654240.SGD","LU1280957306.USD","LU0234572021.USD","LU1983299246.USD","LU2108987350.USD","LU0198837287.USD","BK4581","LU1064131342.USD","LU2461242641.AUD","BK4599","LU0096364046.USD","LLY","LU0097036916.USD","LU0122379950.USD","LU1057294990.SGD","LU2237443895.HKD","LU0823434740.USD","LU2237438978.USD","IE00BJT1NW94.SGD","LU2063271972.USD","LU0238689110.USD","GB00BDT5M118.USD","LU0106261372.USD","LU2471134523.USD","LU1551013342.USD","LU0289739699.SGD","LU2746668461.USD","IE00BK4W5M84.HKD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","SG9999017495.SGD","LU1720051017.SGD","LU0471298694.HKD","LU2750360641.GBP","LU0466842654.USD","BK4007","SG9999018865.SGD","LU0079474960.USD","LU2361044949.HKD","SGXZ99366536.SGD","LU2552382132.HKD","SG9999015986.USD","LU0256863811.USD","BK4516","LU1868837300.USD","LU2237443549.SGD","SG9999018857.SGD","BK4533","LU1804176565.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2558628400","title":"WLFI國庫戰略ALT5 Sigma股價現報5.45美元，較高點跌超40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558628400","media":"Odaily","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558628400?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 23:23","pubTimestamp":1755012223,"startTime":"0","endTime":"0","summary":"<div class=\"line-clamp-4 text-custom-000000/70 dark:text-custom-FFFFFF/60 text-18 font-400 tracking-1 leading-40 whitespace-pre-line\"><p>Odaily星球日报讯 据 Tradingview 数据，ALT 5 Sigma Corporation 现报 5.45 美元，较高点跌幅超过 40%。</p><p><a href=\"https://m.odaily.news/zh-CN/newsflash/442811\" rel=\"noopener noreferrer\" target=\"_blank\">此前消息</a>，ALT 5 Sigma 宣布 15 亿美元融资以启动 World Liberty Financial 国库战略。</p></div>","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.odaily.news/zh-CN/newsflash/443086","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"odaily_live","symbols":["LU1878469433.USD","BK4139","BK4599","ALT"],"gpt_icon":0},{"id":"2558640549","title":"輝瑞藥物聯合療法後期試驗取得積極成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2558640549","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558640549?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 22:00","pubTimestamp":1755007200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ccbdaac7529898eaa28924cf0b474c7c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00B19Z3B42.SGD","SG9999014542.SGD","BK1191","LU0265550946.USD","06078","BK4550","LU1894683348.USD","LU2461242641.AUD","LU2089984988.USD","SG9999001176.SGD","PFE","MRK","IE00BSNM7G36.USD","LU0985481810.HKD","LU2488822045.USD","LU1066051225.USD","LU1989772840.SGD","SG9999011175.SGD","IE00BBT3K403.USD","SG9999014575.USD","IE00BJT1NW94.SGD","LU0106261372.USD","LU1989771016.USD","BK4534","LU1934455863.HKD","LU1989772923.USD","BK1574","LU2468319806.SGD","IE00BLSP4452.SGD","LU0321505868.SGD","LU1699723380.USD","LU1093756168.USD","IE0009355771.USD","LU0737861772.HKD","LU0006306889.USD","LU1934455194.USD","LU2112291526.USD","LU0170899867.USD","01477","LU1430594728.SGD","LU0306806265.USD","LU0289739699.SGD","LU1066053197.SGD","LU2361045086.USD","LU1035773651.USD","IE0002141913.USD","LU0098860793.USD","BK4599","ALPMF","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2558642685","title":"美國食品藥品監督管理局(FDA)正在考慮撤銷輝瑞向5歲以下兒童提供COVID疫苗的授權。","url":"https://stock-news.laohu8.com/highlight/detail?id=2558642685","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558642685?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 20:47","pubTimestamp":1755002856,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1894683348.USD","IE00BBT3K403.USD","LU1066051498.USD","159646","IE00B19Z3B42.SGD","LU0289739699.SGD","BK4592","SG9999011175.SGD","LU0456855351.SGD","PFE","LU0985481810.HKD","SG9999003800.SGD","BK4585","IE00BLSP4452.SGD","LU0225284248.USD","BK4550","LU0225771236.USD","BK4588","LU0234572021.USD","SG9999001176.SGD","SG9999002232.USD","BK4568","IE00B19Z3581.USD","LU1066053197.SGD","LU0321505868.SGD","LU0170899867.USD","LU0122379950.USD","BK4599","SG9999001176.USD","LU0321505439.SGD","SGXZ57979304.SGD","IE000M9KFDE8.USD","IE00BLSP4239.USD","LU0868494617.USD","LU0058720904.USD","LU1023059063.AUD","LU1883839398.USD","SG9999013999.USD","BK4007","LU0306806265.USD","BK4581","LU0306807586.USD","IE0002270589.USD","BK4533","LU1894683264.USD","SG9999002224.SGD","LU1057294990.SGD","BK4534"],"gpt_icon":0},{"id":"2558644030","title":"據彭博新聞社報道，美國食品和藥物管理局考慮撤銷輝瑞公司為 5 歲以下兒童提供的 COVID 疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2558644030","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558644030?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 20:33","pubTimestamp":1755002035,"startTime":"0","endTime":"0","summary":"据彭博新闻社报道，美国食品和药物管理局考虑撤销辉瑞公司为 5 岁以下儿童提供的 COVID 疫苗路透8月12日 - 据彭博新闻社周二报道，美国卫生监管机构正在考虑撤销辉瑞PFE.N销售5岁以下儿童COVID疫苗的授权。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nL4S3U40ZM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306807586.USD","LU0456855351.SGD","LU0289739699.SGD","LU0321505439.SGD","LU0985481810.HKD","BK4007","IE00B19Z3581.USD","LU0170899867.USD","LU1057294990.SGD","SG9999003800.SGD","BK4599","BK4585","LU0058720904.USD","SG9999002232.USD","LU1066051498.USD","LU0306806265.USD","IE00BLSP4452.SGD","LU0321505868.SGD","LU1023059063.AUD","PFE","IE00B19Z3B42.SGD","IE00BLSP4239.USD","LU0122379950.USD","LU1883839398.USD","SG9999002224.SGD","IE00BBT3K403.USD","BK4568","LU0225771236.USD","SGXZ57979304.SGD","SG9999013999.USD","LU1894683348.USD","BK4534","BK4588","BK4592","LU0225284248.USD","LU1894683264.USD","SG9999001176.USD","IE0002270589.USD","IE000M9KFDE8.USD","LU0868494617.USD","SG9999001176.SGD","LU0234572021.USD","BK4533","BK4581","SG9999011175.SGD","LU1066053197.SGD","BK4550"],"gpt_icon":0},{"id":"2558447956","title":"諾和諾德（Novo Nordisk）執行副總裁盧多維克・埃爾福戈特（Ludovic Helfgott）出售股票套現 39","url":"https://stock-news.laohu8.com/highlight/detail?id=2558447956","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558447956?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 20:29","pubTimestamp":1755001747,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0154236417.USD","BK4007","NVO","LU1093756168.USD","LU1093756325.SGD","BK4588","BK4532","BK4585","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4599"],"gpt_icon":0},{"id":"2558850641","title":"高盛最新研報以“2Q25 EPS更新”為主題其中重點對Amylyx(AMLX.US)、CG Oncology(CGON.","url":"https://stock-news.laohu8.com/highlight/detail?id=2558850641","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558850641?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 19:17","pubTimestamp":1754997464,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4516","BK4533","AMLX","BK4135","IE00BFXG1179.USD","CG","IE00BGHQF748.EUR","BK4550","IE0004091025.USD","LU0251131958.USD","BK4127","LU2471134879.HKD","IE0004086264.USD","LU0061475181.USD","LU1868836914.USD","BK4599","GPCR","IDYA","LU2237443465.HKD","IE00BSNM7G36.USD","LU2471134796.USD","IE00B19Z3581.USD","159837","LU1868837136.USD","LU1668664300.SGD","LU0096364046.USD","LU0048573561.USD","LU2237443895.HKD","BK4139","LU2237443622.USD","LU2750360641.GBP","CGON","159399","BK4585","LU0742534661.SGD","BK4504","LU1868836757.USD","LU1868836591.USD","LU2750360997.AUD","LU2471134952.CNY","LU2237438978.USD","LU2237443978.SGD","LU2237443549.SGD","BK4552","LU1894683348.USD","IE00B19Z3B42.SGD","LU1868837300.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2558463116","title":"World Liberty Financial代幣WLFI在ALT5交易中估值0.2美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558463116","media":"Odaily","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558463116?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 18:24","pubTimestamp":1754994258,"startTime":"0","endTime":"0","summary":"<div class=\"line-clamp-4 text-custom-000000/70 dark:text-custom-FFFFFF/60 text-18 font-400 tracking-1 leading-40 whitespace-pre-line\"><p>Odaily星球日报讯 World Liberty Financial 与 ALT 5 Sigma Corporation 达成协议，在此次交易中首次为 WLFI 代币定价，每枚 0.2 美元。ALT 5 计划转型为加密财库公司，发行 20 万股新股并将所得用于收购价值 15 亿美元的 WLFI，其中一半新股将直接与 World Liberty Financial 所持 WLFI 交换。该项目曾于去年 10 月至今年 3 月出售价值 5.5 亿美元的 WLFI 代币，大持仓者包括波场创始人孙宇晨。ALT 5 还将 World Liberty Financial CEO Zach Witkoff、COO Zak Folkman 及美国现任总统特朗普之子 Eric Trump 等增补为董事会成员，三人均持有 WLFI。（DLNews）</p></div>","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.odaily.news/zh-CN/newsflash/443007","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"odaily_live","symbols":["BK4585","COO","ALT","BK4139","LU2211815571.USD","BK4198","LU2272731600.USD","GB00BDT5M118.USD","LU1878469433.USD","LU1992135399.USD","BK4599","LU1992135472.HKD","LU2272731782.SGD","BK4588"],"gpt_icon":0},{"id":"2558643356","title":"輝瑞的聯合療法提高了膀胱癌試驗的生存率","url":"https://stock-news.laohu8.com/highlight/detail?id=2558643356","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558643356?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 17:30","pubTimestamp":1754991016,"startTime":"0","endTime":"0","summary":"辉瑞的联合疗法提高了膀胱癌试验的生存率路透8月12日 - 辉瑞公司PFE.N周二称，其抗癌药物Padcev与默克公司MRK.N的Keytruda联用，在手术前后给药可显著提高肌肉浸润性膀胱癌患者的生存率。在肌肉浸润性膀胱癌中，肿瘤超出了内膜，穿透了器官的肌肉壁。辉瑞公司表示，它计划与全球卫生机构讨论试验结果，以便进行潜在的监管申报。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ccbdaac7529898eaa28924cf0b474c7c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nL4T3U40OP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948541.HKD","LU1066051225.USD","LU1571399168.USD","LU1934455863.HKD","LU0106261372.USD","IE00BLSP4239.USD","LU0321505439.SGD","IE00BBT3K403.USD","LU1291159041.SGD","LU2023250843.SGD","BK4585","BK4599","LU1023059063.AUD","SG9999001176.USD","LU1989772840.SGD","IE00BN8TJ469.HKD","LU1941712348.USD","LU0965509010.AUD","LU1093756325.SGD","LU1037948897.HKD","LU1989771016.USD","LU1883839398.USD","LU1066053197.SGD","LU1116320901.HKD","LU1983299246.USD","LU0861579265.USD","LU0211331839.USD","LU2106854487.HKD","LU1894683348.USD","LU1929549753.HKD","PFE","SG9999002232.USD","BK4592","LU1093756168.USD","IE00BJJMRZ35.SGD","SG9999013999.USD","LU0965508806.USD","MRK","SG9999014575.USD","LU1934455277.USD","SG9999001440.SGD","LU0306806265.USD","LU0058720904.USD","BK4559","LU0985481810.HKD","SG9999015358.SGD","LU1974910355.USD","LU0122379950.USD","LU1934455194.USD","IE000M9KFDE8.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":12,"pageCount":5,"totalSize":226,"code":"91000000","status":"200"}]}}